2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow cositecan: new trials by email Literature Review of cositecan trials Research Report on cositecan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma Karenitecin, Valproic Acid - Malignant Melanoma | Phase 1 / Phase 2 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 42 | 2005-03-01 | 2013-11-25 |
| Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer Karenitecin (BNP1350) - Carcinoma, Carcinoma, Non-Small-Cell Lung | Phase 1 | Completed | BioNumerik Pharmaceuticals, Inc. | 32 | 2004-05-01 | 2020-03-12 |
| Karenitecin in Treating Patients With Recurrent Malignant Glioma karenitecin - Brain and Central Nervous System Tumors | Phase 1 | Completed | National Cancer Institute (NCI) | 2002-01-01 | 2008-07-24 |
Astrocytoma (1) · Brain Neoplasms (1) · Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Gliosarcoma (1) · Melanoma (1) · Neoplasm Metastasis (1) · Oligodendroglioma (1)
BioNumerik Pharmaceuticals, Inc. (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · National Cancer Institute (NCI) (1)
United States (3)
Adil Daud, M.D. (1) · Stuart A. Grossman, MD (1)